Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03042988 · ClinicalTrials.gov registry record · NA

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

A NA study of Hypertension and Multiple System Atrophy, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03042988: Recruiting NA study of Hypertension and Multiple System Atrophy, sponsored by Vanderbilt University Medical Center.

NCT03042988 is a NA study of Hypertension and Multiple System Atrophy that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 20 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03042988, a NA study of Hypertension and Multiple System Atrophy, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Patients with autonomic failure are characterized by disabling orthostatic hypotension (low blood pressure on standing), and at least half of them also have high blood pressure while lying down (supine hypertension). Exposure to heat, such as in hot environments, often worsens their orthostatic hypotension. The causes of this are not fully understood. The purpose of this study is to evaluate whether applying local heat over the abdomen of patients with autonomic failure and supine hypertension during the night would decrease their nocturnal high blood pressure while lying down. This will help us better understand the mechanisms underlying this phenomenon, and may be of use in the treatment of supine hypertension.

Primary Outcome

Maximal change from baseline in systolic blood pressure during the night, measured from 10 pm to 8 am

Interventions

  • OTHER Heating pad
  • OTHER Sham control

Study Locations (1)

Tennessee

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-01-30
Est. Completion 2026-12-30
Phase NA

What NCT03042988 shows while recruiting

NCT03042988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Heating pad is the first listed.

NCT03042988 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT03042988 about?

NCT03042988 is a clinical study titled "Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension". Patients with autonomic failure are characterized by disabling orthostatic hypotension (low blood pressure on standing), and at least half of them also have high blood pressure while lying down (supine hypertension). Exposure to heat, such as in hot environments, often worsens their orthostatic hypo...

What is the current status of trial NCT03042988?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2017-01-30. Estimated completion is 2026-12-30.

What conditions does trial NCT03042988 study?

This clinical trial studies the following conditions: Hypertension, Multiple System Atrophy, Autonomic Failure, Pure Autonomic Failure.

What interventions are being tested in trial NCT03042988?

The interventions under investigation include: Heating pad (OTHER), Sham control (OTHER).

Who is sponsoring clinical trial NCT03042988?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03042988 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03042988's enrollment target sits among peer trials

20 438th of 470 higher than 24 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03042988, the US trial registry maintained by the National Library of Medicine. NCT03042988 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.